AiharaN.; MizukawaK.; KoideK.; MabeH.; NishinoH.Striatal grafts in infarct striatopallidum increase GABA release, reorganize GABAA receptor and improve water maze learning in the rat.Brain Res. Bull.33: 483–488; 1994.
2.
BoerG. J.; GriffioenH. A.Developmental and functional aspects of grafting of the suprachiasmatic nucleus in the Brattleboro and the arrhythmic rat.Eur. J. Morphol.28: 330–345; 1990.
3.
BorlonganC. V.; CahillD. W.; SanbergP. R.Locomotor and passive avoidance deficits following occlusion of the middle cerebral artery.Physiol. Behav.58: 909–917; 1995.
4.
BorlonganC. V.; MartinezR.; ShytleR. D.; FreemanT. B.; CahillD. W.; SanbergP. R.Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery.Pharmacol. Biochem. Behav.52: 225–229; 1995.
5.
BorlonganC. V.; SanbergP. R.Elevated body swing test: A new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism.J. Neurosci.15: 5372–5378; 1995.
6.
BorlonganC. V.; TajimaY.; TrojanowskiJ. Q.; LeeV. M.; SanbergP. R.Transplantation of cryopreserved human embryonal carcinoma-derived neurons (NT2N cells) promotes functional recovery in ischemic rats.Exp. Neurol.149: 310–321; 1998.
7.
BorlonganC. V.; YamamotoM.; TakeiN.; KumazakiM.; UngsuparkornC.; HidaH.; SanbergP. R.; NishinoH.Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia.FASEB J.14: 1307–1317; 2000.
8.
BorlonganC. V.; ZhouF. C.; HayashiT.; SuT. P.; HofferB. J.; WangY.Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.Neurobiol. Dis.8: 636–646; 2001.
9.
BorlonganC. V.; SuT. P.; WangY.Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.Cell Transplant.10: 53–58; 2001.
10.
BorlonganC. V.; SanbergP. R.Neural transplantation for treatment of Parkinson's disease.Drug Discov. Today7: 674–682; 2002.
11.
BorlonganC. V.; SanbergP. R.Neural transplantation in the new millenium.Cell Transplant.11: 615–618; 2002.
12.
BubenikG. A.; BlaskD. E.; BrownG. M.; MaestroniG. J.; PangS. F.; ReiterR. J.; ViswanathanM.; ZisapelN.Prospects of the clinical utilization of melatonin.Biol. Signals Recept.7: 195–219; 1998.
13.
CaiH.; LiZ.; GoetteA.; MeraF.; HoneycuttC.; FeterikK.; WilcoxJ. N.; DudleyS. C.Jr.; HarrisonD. G.; LangbergJ. J.Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke.Circulation106: 2854–2858; 2002.
14.
CastilhoR. F.; HanssonO.; BrundinP.Improving the survival of grafted embryonic dopamine neurons in rodent models of Parkinson's disease.Prog. Brain Res.127: 203–231; 2000.
15.
ChiangY.; MoralesM.; ZhouF. C.; BorlonganC. V.; HofferB. J.; WangY.Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats.Brain Res.889: 200–207; 2001.
Dillon-CarterO.; JohnstonR. E.; BorlonganC. V.; TruckenmillerM. E.; CoggianoM.; FreedW. J.T155g-immortalized kidney cells produce growth factors and reduce sequelae of cerebral ischemia.Cell Transplant.11: 251–259; 2002.
18.
DuC.; HuR.; CsernanskyC. A.; HsuC. Y.; ChoiD. W.Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J.Cereb. Blood Flow Metab.16: 195–201; 1996.
19.
GrabowskiM.; JohanssonB. B.; BrundinP.Fetal neocortical grafts placed in brain infarcts do not improve paw-reaching deficits in adult spontaneously hypertensive rats.Acta Neurochir. Suppl. (Wien)66: 68–72; 1996.
20.
GrosseJ.; DavisF. C.Melatonin entrains the restored circadian activity rhythms of Syrian hamsters bearing fetal suprachiasmatic nucleus grafts.J. Neurosci.18: 8032–8037; 1998.
21.
GuptaY. K.; ChaudharyG.; SinhaK.Enhanced protection by melatonin and meloxicam combination in a middle cerebral artery occlusion model of acute ischemic stroke in rat.Can. J. Physiol. Pharmacol.80: 210–217; 2002.
22.
HagellP.; BrundinP.Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease.J. Neuropathol. Exp. Neurol.60: 741–752; 2001.
23.
IsacsonO.; DeaconT. W.Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat.Neuroscience75: 827–837; 1996.
24.
JohnstonR. E.; Dillon-CarterO.; FreedW. J.; BorlonganC. V.Trophic factor secreting kidney cell lines: In vitro characterization and functional effects following transplantation in ischemic rats.Brain Res.900: 268–276; 2001.
25.
KawashimaS.; YamashitaT.; MiwaY.; OzakiM.; NamikiM.; HiraseT.; InoueN.; HirataK.; YokoyamaM.HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats.Stroke34: 157–163; 2003.
26.
KondohT.; LeeS. H.; LowW. C.Alterations in striatal dopamine release and reuptake under conditions of mild, moderate, and severe cerebral ischemia.Neurosurgery37: 948–954; 1995.
27.
KondohT.; UneyamaH.; NishinoH.; ToriiK.Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats.Life Sci.72: 583–590; 2002.
28.
KondziolkaD.; WechslerL.; GoldsteinS.; MeltzerC.; ThulbornK. R.; GebelJ.; JannettaP.; DeCesareS.; ElderE. M.; McGroganM.; ReitmanM. A.; BynumL.Transplantation of cultured human neuronal cells for patients with stroke.Neurology55: 565–569; 2000.
29.
LeeJ. M.; ZipfelG. J.; ChoiD. W.The changing landscape of ischaemic brain injury mechanisms.Nature399: A7–14; 1999.
30.
LekerR. R.; TeichnerA.; LavieG.; ShohamiE.; LamensdorfI.; OvadiaH.The nitroxide antioxidant tempol is cerebroprotective against focal cerebral ischemia in spontaneously hypertensive rats.Exp. Neurol.176: 355–363; 2002.
31.
LesnikovV. A.; PierpaoliW.Pineal cross-transplantation (old-to-young and vice versa) as evidence for an endogenous “aging clock.” Ann.NY Acad. Sci.719: 456–460; 1994.
32.
LuS. Y.; ShipleyM. T.; NormanA. B.; SanbergP. R.Striatal, ventral mesencephalic and cortical transplants into the intact rat striatum: A neuroanatomical study.Exp. Neurol.113: 109–130; 1991.
33.
MaierC. M.; ChanP. H.Role of superoxide dismutases in oxidative damage and neurodegenerative disorders.Neuroscientist8: 323–334; 1992.
34.
MaierC. M.; SunG. H.; ChengD.; YenariM. A.; ChanP. H.; SteinbergG. K.Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia.Neurobiol. Dis.11: 28–42; 2002.
35.
MarquardtL.; RufA.; MansmannU.; WinterR.; SchulerM.; BuggleF.; MayerH.; GrauA. J.Course of platelet activation markers after ischemic stroke.Stroke33: 2570–2574; 2002.
36.
MeltzerC. C.; KondziolkaD.; VillemagneV. L.; WechslerL.; GoldsteinS.; ThulbornK. R.; GebelJ.; ElderE. M.; DeCesareS.; JacobsA.Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke.Neurosurgery49: 586–592; 2001.
37.
NakaoN.; FrodlE. M.; WidnerH.; CarlsonE.; EggerdingF. A.; EpsteinC. J.; BrundinP.Overexpressing Cu/Zn superoxide dismutase enhances survival of transplanted neurons in a rat model of Parkinson's disease.Nat. Med.1: 226–231; 1995.
38.
NelsonP. T.; KondziolkaD.; WechslerL.; GoldsteinS.; GebelJ.; DeCesareS.; ElderE. M.; ZhangP. J.; JacobsA.; McGroganM.; LeeV. M.; TrojanowskiJ. Q.Clonal human (hNT) neuron grafts for stroke therapy: Neuropathology in a patient 27 months after implantation.Am. J. Pathol.160: 1201–1206; 2002.
39.
NishinoH.; BorlonganC. V.Restoration of function by neural transplantation in the ischemic brain.Prog. Brain Res.127: 461–476; 2000.
40.
PalaogluS.; PalaogluO.; AkarsuE. S.; AyhanI. H.; OzgenT.; ErbengiA.Behavioural assessment of pinealectomy and foetal pineal gland transplantation in rats: Part II.Acta Neurochir. (Wien)128: 8–12; 1994.
41.
PaxinosG.; WatsonC.The rat brain in stereotaxic coordinates.New York: Academic Press; 1986.
42.
PierpaoliW.; Dall'AraA.; PedrinisE.; RegelsonW.The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice.Ann. NY Acad. Sci.621: 291–313; 1991.
43.
PierpaoliW.; RegelsonW.Pineal control of aging: Effect of melatonin and pineal grafting on aging mice.Proc. Natl. Acad. Sci. USA91: 787–791; 1994.
44.
PoulosS. G.; BorlonganC. V.Artificial lighting conditions and melatonin alter motor performance in adult rats.Neurosci. Lett.280: 33–36; 2000.
45.
RedmondD. E.Jr.Cellular replacement therapy for Parkinson's disease—where we are today?Neuroscientist8: 457–488; 2002.
46.
ReiterR. J.; MaestroniG. J.Melatonin in relation to the antioxidative defense and immune systems: Possible implications for cell and organ transplantation.J. Mol. Med.77: 36–39; 1999.
47.
ReiterR. J.; TanD. X.; QiW.; ManchesterL. C.; KarbownikM.; CalvoJ. R.Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo.Biol. Signals Recept.9: 160–171; 2000.
48.
SindenJ. D.; StroemerP.; GrigoryanG.; PatelS.; FrenchS. J.; HodgesH.Functional repair with neural stem cells.Novartis Found Symp.231: 270–283; 2000.
49.
SkaperS. D.; AnconaB.; FacciL.; FranceschiniD.; GiustiP.Melatonin prevents the delayed death of hippocampal neurons induced by enhanced excitatory neurotransmission and the nitridergic pathway.FASEB J.12: 725–731; 1998.
50.
SuzukiM.; TabuchiM.; IkedaM.; TomitaT.Concurrent formation of peroxynitrite with the expression of inducible nitric oxide synthase in the brain during middle cerebral artery occlusion and reperfusion in rats.Brain Res.951: 113–120; 2000.
51.
TabuchiM.; UmegakiK.; ItoT.; SuzukiM.; TomitaI.; IkedaM.; TomitaT.Fluctuation of serum NO(x) concentration at stroke onset in a rat spontaneous stroke model (M SHRSP). Peroxynitrite formation in brain lesions.Brain Res.949: 147–156; 2002.
52.
TakedaH.; SpatzM.; RuetzlerC.; McCarronR.; BeckerK.; HallenbeckJ.Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in spontaneously hypertensive genetically stroke-prone rats.Stroke33: 2156–2163; 2002.
53.
TanD. X.; ManchesterL. C.; ReiterR. J.; QiW.; KimS. J.; El-SokkaryG. H.Melatonin protects hippocampal neurons in vivo against kainic acid-induced damage in mice.J. Neurosci. Res.54: 382–389; 1998.
54.
TanD. X.; ReiterR. J.; ManchesterL. C.; YanM. T.; El-SawiM.; SainzR. M.; MayoJ. C.; KohenR.; AllegraM.; HardelandR.Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger.Curr. Top. Med. Chem.2: 181–197; 2002.
55.
TonderN.; SorensenT.; ZimmerJ.; JorgensenM. B.; JohansenF. F.; DiemerN. H.Neural grafting to ischemic lesions of the adult rat hippocampus.Exp. Brain Res.74: 512–526; 1989.
56.
WalderC. E.; GreenS. P.; DarbonneW. C.; MathiasJ.; RaeJ.; DinauerM. C.; CurnutteJ. T.; ThomasG. R.Ischemic stroke injury is reduced in mice lacking a functional NADPH oxidase.Stroke28: 2252–2258; 1997.
57.
WangY.; ChangC. F.; MoralesM.; ChiangY. H.; HofferJ.Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury.Ann. NY Acad. Sci.962: 423–437; 2002.
58.
WuW.; ScottD. E.; ReiterR. J.No difference in day–night serum melatonin concentration after pineal grafting into the third cerebral ventricle of pinealectomized rats.J. Pineal Res.11: 70–74; 1991.